iShares US Pharmaceuticals ETF
IHE
IHE
130 hedge funds and large institutions have $140M invested in iShares US Pharmaceuticals ETF in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 3 closing their positions.
Holders
130
Holders Change
+17
Holders Change %
+15.04%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
33
Reduced
32
Closed
3
Calls
$651K
Puts
$242K
Net Calls
+$409K
Net Calls Change
+$174K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$15.3M |
2 |
RWP
2
RWA Wealth Partners
Newton,
Massachusetts
|
$3.73M |
3 |
3
Fisher Asset Management
Camas,
Washington
|
$7.21M |
4 |
4
Goldman Sachs
New York
|
$4.05M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$5.18M |